Difference between revisions of "Atovaquone (Mepron)"
m |
Warner-admin (talk | contribs) m (Text replacement - " " to " ") |
||
| (4 intermediate revisions by 3 users not shown) | |||
| Line 1: | Line 1: | ||
==General information== | ==General information== | ||
| − | Class/mechanism: Antiprotozoal, antimicrobial. | + | Class/mechanism: Antiprotozoal, antimicrobial. Hydroxy-1,4-naphthoquinone, analog of ubiquinone, with antipneumocystis activity. Exact mechanism unclear, but may involve inhibition of the electron transport chain in mitochondria and downstream inhibition of nucleic acid and ATP synthesis.<ref name="insert">[https://www.gsksource.com/pharma/content/dam/GlaxoSmithKline/US/en/Prescribing_Information/Mepron/pdf/MEPRON.PDF Atovaquone (Mepron) package insert]</ref><ref>[[:File:Atovaquone.pdf | Atovaquone (Mepron) package insert (locally hosted backup)]]</ref> |
<br>Route: PO (typically as liquid suspension) | <br>Route: PO (typically as liquid suspension) | ||
<br>Extravasation: n/a | <br>Extravasation: n/a | ||
| Line 23: | Line 23: | ||
[[Category:PCP prophylaxis]] | [[Category:PCP prophylaxis]] | ||
| − | [[Category: | + | [[Category:FDA approved in 1992]] |
Revision as of 01:42, 1 June 2023
General information
Class/mechanism: Antiprotozoal, antimicrobial. Hydroxy-1,4-naphthoquinone, analog of ubiquinone, with antipneumocystis activity. Exact mechanism unclear, but may involve inhibition of the electron transport chain in mitochondria and downstream inhibition of nucleic acid and ATP synthesis.[1][2]
Route: PO (typically as liquid suspension)
Extravasation: n/a
For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias such as Micromedex, Lexicomp, Medscape, UpToDate (courtesy of Lexicomp), or the prescribing information.[1]
Diseases for which it is used
No known antineoplastic properties.
Patient drug information
Also known as
- Brand name: Mepron